New York Senate bill in Session 2025-2026.
Status: enacted. Latest action: February 3, 2025.
Relates to the labeling of mifepristone, misoprostol, and their generic alternatives.
Permits prescription labels for mifepristone, misoprostol, and their generic alternatives to include the name of the prescribing health care practice instead of the name of the prescriber at the prescriber's request.
| Date | Event | Detail |
|---|---|---|
| 2024-12-17 | Introduced | Bill introduced |
| 2025-02-03 | Status | enacted |
| 2025-02-03 | Latest Action | Signed by Governor |